China Chinese Patent Medicine Industry Report, 2013-2016
  • Mar./2014
  • Hard Copy
  • USD $2,400
  • Pages:102
  • Single User License
    (PDF Unprintable)       
  • USD $2,200
  • Code: ZZR-001
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $3,400
  • Hard Copy + Single User License
  • USD $2,600
      

Chinese patent medicine refers to the certain dosage forms of medicine, under the guidance of TCM (traditional Chinese medicine) theory, made from traditional Chinese medicinal materials in accordance with specified prescription and standard. Chinese patent medicine industry covers the upstream Chinese herbal medicine production and preliminary processing, the middle pharmaceutical sectors as well as downstream commercial institutions of drug circulation and sales.

Currently, the State is enhancing its support for the Chinese patent medicine industry, successively introducing the Continuing Improving TCM Healthcare Policy, Notice on Conducting Construction of Key Projects of TCM Trade in Services and other favorable policies in 2013. In 2010-2013, China’s Chinese patent medicine industry developed rapidly, with revenue soaring from RMB215.4 billion to RMB448.2 billion at a CAGR of 27.7%.

According to hospital terminal data, Chinese patent medicine for the treatment of cardiovascular and cerebrovascular diseases, tumor diseases and respiratory system diseases are the top three categories of Chinese patent medicine in China, respectively accounting for 37.2%, 15.4% and 11.1% market share in 2012-2013. As far as the distribution of Chinese patent medicine formulations is concerned, there is a clear trend of convergence in injection, and injection formulation products in the top three categories of Chinese patent medicine all made up above 50%.

Cardiovascular and cerebrovascular disease market is the biggest market for Chinese patent medicine, but also the most-variety field with item sales of over RMB500 million. The representative products include ginkgo leaf injection, Shuxuetong injection, Danhong injection, Xingnao injection, and more.

2014031001.png

In the international market, there is a higher recognition of Chinese patent medicine in Asia, especially in Southeast Asia, and many varieties of Chinese patent medicine are included in the Medicare drug list stipulated by Southeast Asian countries, and special departments are established for management research as well. But in the U.S. and European markets, affected by access restrictions and differences in medical health concept, Chinese patent medicine is still only sold as health care product. However, the international market sees strong demand for plant extracts (mostly traditional Chinese medicinal materials) whose export value in 2010-2013 grew at a CAGR of 44% and accounted for approximately 50% of China’s TCM export value.

China Chinese Patent Medicine Industry Report, 2013-2016 mainly covers the followings:
20120114.gifIntroduction to China’s Chinese patent medicine industry chain as well as domestic and foreign policies, consumer trends and industry trends;
20120114.gifDevelopment situation, supply and demand, import and export, regional analysis, industry chain segments, etc. of Chinese patent medicine industry;
20120114.gifChina’s Chinese patent medicine market segments, involving Chinese patent medicine for the treatment of cardiovascular and cerebrovascular diseases, tumor diseases, etc.;
20120114.gifProfile and analysis, development prospect and earnings forecast, industry trends and market forecast of key Chinese patent medicine manufacturers in China.

1. Overview of Chinese Patent Medicine
1.1 Definition and Characteristics
1.2 Classification
1.2.1 Classification by Dosage Form
1.2.2 Classification by Pharmacology
1.2.3 Industry Chain

2. Operating Environment for Chinese Patent Medicine Industry
2.1 Policies
2.1.1 Domestic Policies
2.1.2 Foreign Policies
2.2 Consumer Trends
2.3 Industry Trends

3. Chinese Patent Medicine Market
3.1 Development Status
3.2 Demand
3.2.1 Regional Demand 
3.2.2 Product Demand Structure
3.2.3 Trends
3.3 Supply
3.3.1 Yield Analysis and Key Areas
3.3.2 Industry Concentration
3.4 Regional Analysis of Players
3.5 Import and Export
3.5.1 Import
3.5.2 Export
3.5.3 Import-Export Structure
3.6 Traditional Chinese Medicinal Materials
3.6.1 Resources 
3.6.2 Price Trend
3.7 Traditional Chinese Medicine Decoction Pieces (Chinese Herbal Medicines for Primary Processing)
3.7.1 Industry Status
3.7.2 Industry Trends
3.8 Plant Extract
3.8.1 Development Status
3.8.2 Import and Export

4. Chinese Patent Medicine Market Segments in China
4.1 Chinese Patent Medicine for Cardiovascular and Cerebrovascular Diseases
4.2 Chinese Patent Medicine for Tumor Diseases
4.3 Chinese Patent Medicine for Respiratory System Diseases
4.4 Chinese Patent Medicine for Musculoskeletal Diseases

5. Key Enterprises
5.1 Tianjin Tasly Pharmaceutical Co., Ltd.
5.1.1 Profile 
5.1.2 Operation
5.1.3 Revenue Structure
5.1.4 Gross Margin
5.1.5 Prospects
5.2 Guizhou Yibai Pharmaceutical Co., Ltd.
5.2.1 Profile
5.2.2 Operation
5.2.3 Revenue Structure
5.2.4 Gross Margin
5.2.5 Prospects
5.3 Yunnan Baiyao Group Co., Ltd.
5.3.1 Profile
5.3.2 Operation
5.3.3 Revenue Structure
5.3.4 Gross Margin
5.3.5 Prospects
5.4 Zhangzhou Pientzehuang Pharmaceutical Co., Ltd.
5.4.1 Profile
5.4.2 Operation
5.4.3 Revenue Structure
5.4.4 Gross Margin
5.4.5 Prospects
5.5 Shandong Dong-E E-Jiao Co., Ltd.
5.5.1 Profile
5.5.2 Operation 
5.5.3 Revenue Structure
5.5.4 Gross Margin
5.5.5 Prospects
5.6 China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (CR Sanjiu)
5.6.1 Profile
5.6.2 Operation
5.6.3 Revenue Structure
5.6.4 Gross Margin
5.6.5 Prospects
5.7 Shanghai Kaibao Pharmaceutical Co., Ltd.
5.7.1 Profile
5.7.2 Operation
5.7.3 Revenue Structure
5.7.4 Gross Margin
5.7.5 Prospects
5.8 Kangmei Pharmaceutical Co., Ltd.
5.8.1 Profile
5.8.2 Operation
5.8.3 Revenue Structure
5.8.4 Gross Margin
5.8.5 Prospects
5.9 Tibet Rhodiola Pharmaceutical Holding Co., Ltd.
5.9.1 Profile
5.9.2 Operation
5.9.3 Revenue Structure
5.9.4 Gross Margin
5.9.5 Prospects
5.10 Beijing Tongrentang Co., Ltd. (TRT)
5.10.1 Profile
5.10.2 Operation
5.10.3 Revenue Structure
5.10.4 Gross Margin
5.10.5 Prospects

6. Summary and Forecast
6.1 Comparison of Domestic Key Chinese Patent Medicine Enterprises
6.1.1 Revenue
6.1.2 Gross Margin
6.2 Industry Forecast
6.2.1 Industry Trends
6.2.2 Market Forecast
Advantages and Disadvantages of Chinese Patent Medicine
Classification of Chinese Patent Medicine by Dosage Form
Classification of Chinese Patent Medicine by Pharmacology
Chinese Patent Medicine Industry Chain
Recent National Policies on Chinese Patent Medicine
Chinese herbal medicine production support projects, 2013
Percentage of Chinese Patent Medicine Output Value in Total Output Value of Pharmaceutical Industry, 2009-2012
Number of Chinese Patent Medicine Enterprises in China, 2010-2013
Revenue and YoY Growth Rate of Chinese Patent Medicine Industry in China, 2010-2013
Total Profit and YoY Growth Rate of Chinese Patent Medicine Industry in China, 2010-2013
Gross Margin of Chinese Patent Medicine Enterprises in China, 2012-2013
China’s Top 7 Regions by Chinese Patent Medicine Sales, 2012
China’s Chinese Patent Medicine Sales Structure by Top 7 Regions, 2012
China’s Chinese Patent Medicine Hospital Terminal Sales Structure by Type of Diseases Treated, 2012
Revenue and Share in Pharmaceutical Industry of China's Chinese Patent Medicine Industry, 2010-2013
China's Population Aged 65 and Above, 2002-2013
Per Capita Healthcare Expenditure of China's Urban and Rural Residents, 2002-2012
Average Annual Air Pollution Index in Some Key Cities Nationwide, 2013
Output and YoY Growth Rate of Chinese Patent Medicine in China, 2010-2013
China’s Top 5 Regions by Chinese Patent Medicine Output, 2013
Market Share Ranking of Chinese Patent Medicine for Cardiovascular and Cerebrovascular Diseases
Market Share Ranking of Chinese Patent Medicine for Tumor Diseases
Market Share Ranking of Chinese Patent Medicine for Musculoskeletal Diseases
Market Share Ranking of Gynecological Products
Top 10 Chinese Provinces/Municipalities by Number of Above-scale Chinese Patent Medicine Enterprises, 2012
Top 10 Chinese Provinces/Municipalities by Sales of Chinese Patent Medicine Enterprises, 2012
Chinese Provinces/Municipalities with Gross Margin of Chinese Patent Medicine Enterprises Above 40%, 2012
Number of Enterprises, Sales and Total Profit of China's Chinese Patent Medicine Market by Region, 2012
China's Chinese Patent Medicine Import Value and YoY Growth Rate, 2010-2013
China’s Traditional Chinese Medicinal Materials and Traditional Chinese Medicine Decoction Pieces Import Value and YoY Growth Rate, 2010-2013
China’s Plant Extract Import Value and YoY Growth Rate, 2010-2013
China's Chinese Patent Medicine Export Value and YoY Growth Rate, 2010-2013
China’s Traditional Chinese Medicinal Materials and Traditional Chinese Medicine Decoction Pieces Export Value and YoY Growth Rate, 2010-2013
China’s Plant Extract Export Value and YoY Growth Rate, 2010-2013
Proportion of Export Value of China’s Plant Extracts in TCM Commodities, 2010-2013
TCM Commodities Export Value by Region, Jan-Sep 2013
China’s Top 10 Chinese Patent Medicine Exporting Enterprises, 2011
China’s Top 5 Chinese Patent Medicine Exporting Enterprises, 2012
Trade Gap between China’s Chinese Patent Medicine Imports and Exports, 2010-2013
Proportion of China’s Plant Extract Export Value, 2010-2013
Trend Chart of Traditional Chinese Medicinal Material Comprehensive 200 Index, 2007-2013
Price Index of Traditional Chinese Medicinal Materials in Chengdu, China, 2010-2013
Major Traditional Chinese Medicinal Material GAP Enterprises in China, 2012
Revenue and Net Income of Traditional Chinese Medicine Decoction Pieces Industry, 2010-2013
China's Plant Extract Export Destination Structure by Export Value, 2012
Four Major Series of Chinese Patent Medicine for Cardiovascular and Cerebrovascular Diseases
Share of Chinese Patent Medicine for Cardiovascular and Cerebrovascular Diseases in the Chinese Patent Medicine Sold to Hospitals in China, 2008-2012
Distribution of Dosage Forms of Chinese Patent Medicine for Cardiovascular and Cerebrovascular Diseases, 2012
Excellent Brands of Chinese Patent Medicine for Cardiovascular and Cerebrovascular Diseases, 2012
Share of Chinese Patent Medicine for Tumor Diseases in the Chinese Patent Medicine Sold to Hospitals in China, 2008-2012
Distribution of Dosage Forms of Chinese Patent Medicine for Tumor Diseases in Some Key Cities, 2012
Top 10 Excellent Brands of Chinese Patent Medicine for Tumor Diseases in China, 2012
Share of Chinese Patent Medicine for Respiratory System Diseases in the Chinese Patent Medicine Sold to Hospitals in China, 2008-2012
Chinese Patent Medicine for Respiratory System Diseases in Sample Hospital by Type, 2012
Excellent Brands of Chinese Patent Medicine for Respiratory System Diseases, 2012
Share of Chinese Patent Medicine for Musculoskeletal Diseases in the Chinese Patent Medicine Sold to Hospitals in China, 2008-2012
Distribution of Dosage Forms of Chinese Patent Medicine for Musculoskeletal Diseases in Sample Hospital, 2012
China's Top 10 Excellent Brands of Traditional Chinese Medicine for Musculoskeletal Diseases, 2012
Revenue and Net Income of Tasly, 2010-2013
Revenue Breakdown of Tasly by Sector, 2010-2013
Revenue Breakdown of Tasly by Region, 2010-2013
Gross Margin of Tasly by Sector, 2010-2013
Gross Margin of Tasly by Region, 2010-2013
Revenue and Net Income of Tasly, 2012-2016E
Revenue and Net Income of Yibai Pharmaceutical, 2010-2013
Revenue Breakdown of Yibai Pharmaceutical by Product, 2010-2013
Gross Margin of Yibai Pharmaceutical by Product, 2010-2013
Revenue and Net Income of Yibai Pharmaceutical, 2012-2016E
Revenue and Net Income of Yunnan Baiyao, 2010-2013
Revenue Breakdown of Yunnan Baiyao by Product, 2010-2013
Revenue Breakdown of Yunnan Baiyao by Region, 2010-2013
Gross Margin of Yunnan Baiyao by Product, 2010-2013
Gross Margin of Yunnan Baiyao by Region, 2010-2013
Revenue and Net Income of Yunnan Baiyao, 2012-2016E
Revenue and Net Income of Pien Tze Huang, 2010-2013
Revenue Breakdown of Pien Tze Huang by Sector, 2010-2013
Revenue Breakdown of Pien Tze Huang by Region, 2010-2013
Gross Margin of Pien Tze Huang by Product, 2010-2013
Gross Margin of Pien Tze Huang by Region, 2010-2013
Revenue and Net Income of Pien Tze Huang, 2012-2016E
Revenue and Net Income of Dong-E E-Jiao, 2010-2013
Revenue Breakdown of Dong-E E-Jiao by Product, 2010-2013
Revenue Breakdown of Dong-E E-Jiao by Region, 2010-2013
Gross Margin of Dong-E E-Jiao by Product, 2010-2013
Gross Margin of Dong-E E-Jiao by Region, 2010-2013
Revenue and Net Income of Dong-E E-Jiao, 2012-2016E
Revenue and Net Income of CR Sanjiu, 2010-2013
Revenue Breakdown of CR Sanjiu by Sector, 2010-2013
Revenue Breakdown of CR Sanjiu by Product, 2010-2013
Gross Margin of CR Sanjiu by Sector, 2010-2013
Revenue and Net Income of CR Sanjiu, 2012-2016E
Revenue and Net Income of Shanghai Kaibao, 2010-2013
Revenue Breakdown of Shanghai Kaibao by Product, 2010-2013
Revenue Breakdown of Shanghai Kaibao by Region, 2010-2013
Gross Margin of Shanghai Kaibao by Product, 2010-2013
Revenue and Net Income of Shanghai Kaibao, 2012-2016E
Revenue and Net Income of Kangmei Pharmaceutical, 2010-2013
Revenue Breakdown of Kangmei Pharmaceutical by Product, 2010-2013
Gross Margin of Kangmei Pharmaceutical by Product, 2010-2013
Revenue and Net Income of Kangmei Pharmaceutical, 2012-2016E
Revenue and Net Income of Tibet Rhodiola Pharmaceutical, 2010-2013
Revenue Breakdown of Tibet Rhodiola Pharmaceutical by Product, 2010-2013
Revenue Breakdown of Tibet Rhodiola Pharmaceutical by Region, 2010-2013
Gross Margin of Tibet Rhodiola Pharmaceutical by Product, 2010-2013
Gross Margin of Tibet Rhodiola Pharmaceutical by Region, 2010-2013
Revenue and Net Income of Tibet Rhodiola Pharmaceutical, 2012-2016E
Revenue and Net Income of Tongrentang, 2010-2013
Revenue Breakdown of Tongrentang by Region, 2010-2013
Gross Margin of Tongrentang by Region, 2010-2013
Revenue and Net Income of Tongrentang, 2012-2016E
Revenue of Some Key Chinese Patent Medicine Enterprises in China, Jan-Sep 2013 
Gross Margin of Some Key Chinese Patent Medicine Enterprises in China, Jan-Jun 2013 
Revenue of Chinese Patent Medicine Industry in China, 2013-2016E

China Vitamin Industry Report,2014-2017

China is the world's largest production base of vitamins, with vitamin C and vitamin E as its most important products, wherein vitamin C and related products account for more than 60% of its total out...

China Chemical Pharmaceutical Industry Report, 2013-2016

Chemical pharmaceutical consists mainly of chemical drug preparation and active pharmaceutical ingredient (API), and the gross margin of chemical drug preparation industry is generally higher than tha...

China Pharmaceutical Distribution Industry Report, 2013

Thanks to the continuous advancement in new medical reform, China’s pharmaceutical distribution industry has maintained a fairly rapid growth in recent years, with the sales value showed a CAGR of rou...

China Pharmaceutical Glass Packaging Industry Report, 2013-2016

Influenced by the substitution of plastic, aluminum foil and other new packaging materials as well as the declining packaging material purchase prices incurred by the medical reform, China pharmaceuti...

China Chinese Patent Medicine Industry Report, 2013-2016

Chinese patent medicine refers to the certain dosage forms of medicine, under the guidance of TCM (traditional Chinese medicine) theory, made from traditional Chinese medicinal materials in accordance...

Global and China Monoclonal Antibody Industry Report, 2013-2017

Currently, monoclonal antibody agents have been successfully used in the treatment of tumors, cancers and other serious diseases as a heavyweight in the biopharmaceutical industry. In 2009-2012, the m...

Global and China Insulin Industry Report, 2013-2017

As the third largest human health disease following neoplastic disease, cardiovascular and cerebrovascular diseases, the number of diabetic patients has continued growing from 246 million in 2007 to 3...

China Large Volume Parenteral (LVP) Industry Report, 2013-2015

Under the context of China's medical reform and sustainable development of the pharmaceutical market, the output and demand of Large Volume Parenteral (LVP) which is one of the top five Chinese prepar...

China Vitamin Industry Report, 2012-2015

As a great power of vitamin production and export, China has long been known as the world’s vitamin production base. In recent years, its vitamin exports on external demand accounted for about 80% of ...

China Pharmaceutical Equipment Industry Report, 2012-2015

Driven by the new GMP certification as well as the brisk downstream demand, China pharmaceutical equipment industry has seen steady progress in sales volume and technological content of products over ...

China Genetic Engineering Drug Industry Report, 2011-2012

China gets a late start in developing genetic engineering drug industry, but has achieved leapfrog advance. At present, China has at least one hundred enterprises involved in genetic engineering drugs...

China Animal Vaccine Industry Report, 2011-2012

Along with the frequent outbreaks of animal epidemics, the government’s increasing investment in epidemic prevention and the implementation of compulsory immunization system, Chinese animal vaccine ma...

China Human Vaccine Industry Report, 2011-2012

After decades of development, China has become one of the major producer and consumers of human vaccine around the world. In 2011, human vaccine manufacturers numbered 38 in China and the lot release ...

China Chemical Pharmaceutical Industry Report, 2011

In Jan.-Aug., 2011, the gross industrial output value of Chinese chemical pharmaceutical industry surged by 24.54% YoY to RMB460.531 billion, up 2.67 percentage points over the same period of last yea...

China Pharmaceutical Equipment Industry Report, 2011-2012

In recent years, Chinese pharmaceutical equipment industry has witnessed significant growth in both product quality and technological content, as well as steady rise of sales volume. According to Chin...

China Animal Vaccine Industry Report, 2010-2011

China animal vaccine industry has been fast-growing. The market maintained an average annual growth rate up to 13.6% in 2006-2010, and reached around RMB 7.5 billion in 2010, up 21.0% YoY. With the in...

China Human Vaccine Industry Report, 2010-2011

With the improvement of economy and people’s disease prevention awareness, China’s human vaccine market has expanded in recent years, growing at a CAGR of 24.0% in 2007-2010. In particular, the market...

China Pharmaceutical Chain Industry Report, 2010

Recent years have seen rapid growth of China’s pharmaceutical retail market, with expanding scale of chain enterprises and increasing number of drugstores, thanks to a fast-growing pharmaceutical indu...

2005-2014 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号
在线客服系统